[HTML][HTML] Combination of epidrugs with immune checkpoint inhibitors in cancer immunotherapy: From theory to therapy

R Guo, J Li, J Hu, Q Fu, Y Yan, S Xu, X Wang… - International …, 2023 - Elsevier
Immunotherapy based on immune checkpoint inhibitors (ICIs) has revolutionized treatment
strategies in multiple types of cancer. However, the resistance and relapse as associated …

Decoding the oncogenic signals from the long non-coding RNAs

R Nadhan, DN Dhanasekaran - Onco, 2021 - mdpi.com
Simple Summary Long non-coding RNAs (lncRNA), which are often referred to as “Genomic
Dark Matter”, are emerging as critical molecules involved in the regulation of multiple …

[HTML][HTML] A deep transcriptome meta-analysis reveals sex differences in multiple sclerosis

JF Català-Senent, Z Andreu, MR Hidalgo… - Neurobiology of …, 2023 - Elsevier
Background Multiple sclerosis (MS), a chronic auto-immune, inflammatory, and
degenerative disease of the central nervous system, affects both males and females; …

Exploring potential roles of long non-coding RNAs in cancer immunotherapy: a comprehensive review

A Arshi, E Mahmoudi, F Raeisi… - Frontiers in …, 2024 - frontiersin.org
Cancer treatment has long been fraught with challenges, including drug resistance,
metastasis, and recurrence, making it one of the most difficult diseases to treat effectively …

Expression Profiles of Long Non-Coding RNA GAS5 and MicroRNA-222 in Younger AML Patients

D Pavlovic, N Tosic, B Zukic, Z Pravdic, NS Vukovic… - Diagnostics, 2021 - mdpi.com
Acute myeloid leukemia (AML) is a heterogeneous malignant disease both on clinical and
genetic levels. AML has poor prognosis and, therefore, there is a constant need to find new …

[HTML][HTML] Long Non-Coding RNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications

S Basu, R Nadhan, DN Dhanasekaran - Cancers, 2025 - mdpi.com
Abstract Background/Objectives: Ovarian cancer is a leading cause of gynecological cancer
mortality worldwide, often diagnosed at advanced stages due to vague symptoms and the …

A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer

Y Peng, H Wang, Q Huang, J Wu, M Zhang - Journal of Ovarian Research, 2022 - Springer
Abstract Background Long noncoding RNAs (lncRNAs) are important regulators of gene
expression and can affect a variety of physiological processes. Recent studies have shown …

[HTML][HTML] Oncogenic role of SKA2 and its ceRNA network in hepatocellular carcinoma based on a comprehensive analysis

W Hu, X Hu, Y Zhu, M Li, H Meng… - Translational Cancer …, 2024 - pmc.ncbi.nlm.nih.gov
Background Genetic alterations have important roles in cancer development and
progression. SKA2 (spindle and kinetochore associated complex subunit 2) is a mitotic …

[HTML][HTML] Long non-coding RNA (LncRNA) CHROMR promotes the expression of the CNNM1 gene by adsorbing hsa-miR-1299 to obtain drug resistance in diffuse …

M Wang, Z Miao, H Cen, J He, C Wei - Translational Cancer …, 2022 - ncbi.nlm.nih.gov
Long non-coding RNA (LncRNA) CHROMR promotes the expression of the CNNM1 gene by
adsorbing hsa-miR-1299 to obtain drug resistance in diffuse large B lymphoma cells - PMC …

[PDF][PDF] LncRNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications

S Basu, R Nadhan, DN Dhanasekaran - 2024 - preprints.org
Background/Objectives: Ovarian cancer is a leading cause of gynecological cancer mortality
worldwide, often diagnosed at advanced stages due to vague symptoms and lack of …